Article Text

Download PDFPDF

890 Nivolumab plus ipilimumab in anti-PD(L)-1 naïve and experienced HCC patients — single institute experience in Taiwan

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.